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Purpose: Recent reports suggest that 80% to 90% of patients can safely undergo carotid 
endarterectomy on the basis of duplex scanning alone without cerebral angiography. Other 
investigators have recommended that a complementary, imaging study such as magnetic 
resonance angiography (MRA) also be obtained. 
Methods: We prospectively evaluated 103 consecutive patients with carotid occlusive 
disease. Eighty percent of patients were symptomatic. All 103 patients underwent duplex 
scanning and arteriography. Additional noninvasive t sts included computed tomography, 
magnetic resonance imaging, and MRA in 50%, 56%, and 48% of patients, respectively. At
a multispecialty conference all studies except angiograms were reviewed, and a treatment 
decision was made by a panel of attending vascular surgeons, neurosurgeons, and 
neurologists. The cerebral angiograms then were reviewed and changes made to final 
treatment plans were noted. 
Results:After review ofnoninvasive studies, 30 of 103 of patients (29%) were believed to 
require arteriography because of diagnostic uncertainty of carotid occlusion in three 
patients, suggestion of nonatherosclerotic d sease in four, suggestion of proximal disease 
in two, suboptimal noninvasive studies in one, and uncertainty of therapy despite 
good-quality noninvasive studies in 20 patients primarily with borderline stenoses and 
unclear symptoms. In 10 of these 30 patients (33%) management decisions were changed 
on the basis of angiogram results. Of the remaining 73 patients (71%) in whom the panel 
felt comfortable proceeding with operative or medical therapy without angiography, only 
one patient (1.4%) would have had management altered by results of angiography. MRA 
results concurred with duplex findings in 92% of studies, but did not alter management i  
any patient. 
Conclusions: In patients with good-quality duplex images, focal atherosclerotic bifurcation 
disease, and clear clinical presentation, treatment decisions can be made without 
arteriography. In 30% of patients angiography is useful in clarifying decisionmaking. MRA 
is unlikely to influence management decisions and is thus rarely indicated. (J Vasc Surg 
1996;23:950-6.) 
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The benefit of  carotid endarterectomy for high- 
grade internal carotid artery stenoses has been shown 
for symptomatic patients in the North Ameri- 
can Symptomatic Carotid Endarterectomy Trial 
(NASCET) 1 and the European Carotid Surgery Trial 
(ECST), 2 and for asymptomatic patients in the re- 
cently completed Asymptomatic Carotid Atheroscle- 
rosis Study (ACAS). 3 Each of these trials used angiog- 
raphy as the definitive diagnostic test to determine the 
degree of carotid artery stenosis and to select patients 
for surgery. 
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Recent studies, however, have questioned the role 
ofarteriography as the gold standard in the evaluation 
of carotid occlusive disease. 4-7 Angiography may un- 
derestimate he degree of carotid stenosis, particularly 
web-like lesions, and gives no hemodynamic orphysi- 
ologic information. Contrast angiography has also 
been noted to have a 0.5% to 4% incidence of 
neurologic omplications--almost half of the neuro- 
logic morbidity observed in ACAS was the direct 
result of angiography. 3 Angiography also results in 
complications atthe arterial puncture site in approxi- 
match/ 5% of patients and contrast-induced renal 
dysfunction in 1% to 5%. Obviously it would be 
beneficial and cost-effective if significant numbers of 
patients could be safely evaluated and treated for 
cercbrovascular disease without angiography. 
Color-flow duplex imaging (CFD), and magnetic 
resonance angiography (MRA) are two noninvasive 
imaging methods that can detect and grade carotid 
bifurcation disease. Most centers routinely perform 
CFD as part of the initial workup of patients with 
cercbrovascular disease. CFD has been shown to 
correlate well with angiography. 6-8 MRA renders an 
image similar to that of conventional rteriography, 
although it tends to overestimate the degree of 
stenosis, 8 9 MRA has the advantage of imaging the 
intracranial circulation and, if combined with mag- 
netic resonance imaging (MRI), can give accurate 
images of the brain parenchyma, l° 
Several centers have reported exemplary results of 
carotid endartercctomy performed with CFD alone 
or in combination with MRA. 1~-1s Nonetheless, well- 
defined criteria to delineate patients who are ame- 
nable to noninvasive workup are not available. It has 
also proved difficult to develop criteria that reliably 
correlate CFD and MRA findings with arteriogra- 
phy, 16-21 particularly to define the 70% angiographic 
stenosis that was found to be important in NASCET 
and ECST (which is even more difficult because 
NASCET and ECST used different criteria to define 
70% angiographic stenosis)Y -24 
This study was undertaken to define the relative 
contribution of CFD, MRA, and angiography in a 
prospective protocol and to determine which patients 
could be safely managed on the basis of the findings of 
noninvasive studies. We also wished to delineate the 
need for MRA in the workup, particularly to see 
whether some patients could be spared arteriography 
on the basis of the result of MRA. 
PATIENTS AND METHODS 
Between Iuly 1, 1994, and March 31, 1995, 110 
consecutive patients were evaluated for cerebrovascu- 
lar disease at the University Medical Center (and 
Tucson Veterans Administration [VA] Medical Cen- 
ter) and the University of Colorado (and Denver VA 
Medical Center). Seven patients eventually were ex- 
cluded from the review as a result of protocol viola- 
tions (explained below) leaving 103 patients for 
evaluation. Sixty-one patients were evaluated at the 
University of Arizona, 22 at the Denver VA, and 20 at 
the Tucson VA. Sixty-seven were male and 36 were 
female; the mean age was 68 years (range, 34 to 93 
years). 
Atherosclerotic risk factors were prevalent. Hy- 
pertension was present in 74% of patients, coronary 
artery disease in 54%, hyperlipidemia in 53%, and 
diabetes in 17%. Thirty-seven percent of patients were 
currently smoking, 51% had smoked in the past, and 
i2% had never smoked. Cerebrovascular symptoms 
were present in 80% of patients (transient ischemic 
attack in 34, recent stroke in 20, amaurosis fugax in 
13, both transient ischemic attack and previous troke 
in 12, and vertebrobasilar symptoms in 3). The 
remaining 20% were asymptomatic. Eighteen patients 
(17.5%) had undergone previous carotid endarterec- 
tomy (contralateral to current symptoms in 12, ipsi- 
lateral to current symptoms in 5, and bilateral in I). At 
the time of presentation 62 patients (60%) were taking 
aspirin, nine patients (9%) warfarin, one patient (1%) 
ticlopidine, and one patient (1%) both aspirin and 
warfarin. Thirty patients (29%) were not receiving 
antiplatelet therapy or anticoagulants at the time of 
presentation. 
For entry into the protocol all patients required 
CFD and angiography performed within 30 days of 
one another. Of the seven patients excluded from this 
review, five lacked angiography and two lacked CFD. 
All vascular laboratories that performed studies were 
accredited by the Intersocietal Commission for the 
Accreditation of Vascular Laboratories. We attempted 
to perform MRI and MRA in as many patients as 
possible. CFD images were obtained with an ATL 
Ultramark 9 HDI system (Advanced Technologies 
Laboratories; Bothell, Wash.) or an Ultrasonics 750 
SD duplex imager (Ultrasonics Inc.; Yonkers, N.Y.). 
MRI and MRA were performed in a 1.5 Tesla Signa 
system (General Electric Corporation; Milwaukee, 
Wise.). Angiograms were obtained with conventional 
and digital techniques on imaging systems manufac- 
tured by Toshiba (Tokyo, Japan) or Siemens (Erlang- 
en, Germany). 
CFD images were interpreted using criteria based 
on peal~ systolic and end diastolic frequencies in 
the internal carotid artery, along with internal 
carotid-to-common carotid artery ratios as sug- 
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Fig. 1. Treatment decisions based on duplex scan alone 
were altered 11% of the time after arteriography. 
gested by Moneta and associates 25 to better stratify 
patients within the 50% to 79% category of stenosis. 
Angiograms were interpreted using the measurement 
criteria set forth in NASCET (minimum 1CA diam- 
eter compared with the normal ICA diameter distal to 
the stenosis).~ MRA was performed both in 2D phase 
contrast with sagittal and coronal sections and in 2D 
time-of-flight with 1.5-mm transverse cuts. Phase 
contrast was used for a screening view and for the 
vertebrobasilar nd intracranial rteries, whereas the 
time-of-flight sequences were used for maximal reso- 
lution of the carotid bifurcation. Available computer 
software did not provide interpretable images of the 
aortic arch or supraaortic trunks. Computed tomo- 
graphic (CT) images of the brain were included if 
available (all performed on new-generation scanner). 
All cases were presented at a multidisciplinary 
cerebrovascular conference. After the pertinent his- 
tory and physical and risk-factor evaluation, the 
CFDs, CTs, MRIs, and MRAs, if available, were 
evaluated. At the time of review all noninvasive studies 
were graded for image quality as good, fair, or poor. 
Attending vascular surgeons, neurosurgeons, and 
neurologists who were unaware of the results of 
angiographic s ans then made independent treatment 
decisions on the basis of the available data. The 
panelists also determined whether arteriography 
would be likely to furnish additional useful informa- 
tion. The angiograms then were reviewed and the 
management plans again recorded, including any 
changcs prompted by thc angiograms. Panelists wcre 
not blinded to the opinions of the other panelists, but 
all opinions were stated in succession. In the case of 
differing opinions, each panelist's opinion was re- 
corded along with the management decision made 
after arteriography. The same panel reviewed all 
University of Arizona and Tucson VA cases. The 
Denver VA cases were reviewed by a different panel 
with the same methods. The Arizona panel reviewed 
the Denver VA results and decided that all decisions 
were appropriate. 
RESULTS 
All 103 patients underwent CFD and cerebral 
angiography. Additional noninvasive tests included 
CT, MRI, and MRAin 50%, 56%, and 48% of patients, 
respectively. Only 4% of CFDs, 2% of CTs, 3% of 
MRIs, 16% of MRAs, and 2% of angiograms were 
graded as of fair or poor quality; the remainder were 
graded as good. 
Brain imaging, including CT and MRI, did not 
disclose any unsuspected disease, such as mass lesions, 
aneurysm, or arteriovenous malformation. CT often 
showed normal results in patients with acute stroke. 
Intracranial hemorrhage was not noted in any patient. 
MRI was better at showing deep white matter 
changes. Brain imaging did not alter clinical manage- 
ment in any case. 
The correlation of arteriography with CFD was 
excellent (~c = 0.716 + 0.04). The usual areas of dis- 
agreement were in patients with moderate stenoses. 
In this group CFD tended to lead to a slightly greater 
estimate of the degree of stenosis than did arteriog- 
raphy. 
Overall, cerebral angiography altered the manage- 
mcnt of patients who were being evaluated for cere- 
brovascular disease 11% of the time (Fig. 1). In 73 
patients operative indications, symptoms, and CFD 
findings were consistent, and the panel felt comfort- 
able proceeding with operative or medical therapy 
without angiography. In this subgroup of patients, 
angiography changed management in only one pa- 
tient, in whom angiography revealed only an S-curve 
in the carotid rather than a high-grade stenosis. MRA 
concurred with CFD findings in 92% of studies, but 
did not alter management i  any patient. 
After review ofnoninvasive studies, 30 of the 103 
patients (29%) were believed to require arteriography 
before a confident clinical decision could be made. 
Indications for angiography in these 30 patients are 
listed in Table I. Arteriography was believed necessary 
only in five asymptomatic patients and was always the 
result of uncertainty regarding the degree ofstenosis 
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Fig. 2. Influence ofarteriography on clinical management based on whether panel decided that 
clinical history and noninvasive t sts were compatible and conclusive. 
or to confirm occlusion shown by CFD. The other 25 
patients had symptomatic cerebrovascular disease. In 
10 of the 30 patients (33%) management decisions 
were changed on the basis of angiogram results 
(Fig. 2). In six patients, medical therapy was chosen 
rather than operative therapy because angiography 
downgraded the severity of the stenosis. In four 
patients, operative therapy was recommended rather 
than medical therapy because angiography revealed 
severe ulceration (two patients), or a high-grade ICA 
stenosis that had been considered occluded because of 
CFD results (two patients). Both patients with false 
positive findings of carotid occlusion by CFD also 
underwent MRA. Although one of these MRAs did 
demonstrate a string sign, the other was of poor 
quality and was nondiagnostic. In only three catego- 
ries in Table I did angiography actually alter manage- 
ment decisions. These categories were patients with 
50% to 79% stenoses by CFD with confounding 
variables, those with high-grade stenoses contralateral 
to a carotid occlusion, and those who required 
confirmation of an occluded internal carotid artery. 
Two patients had demonstration fintracranial neu- 
rysms that were elected to be followed conservatively. 
Only two patients were found to have significant 
aortic arch lesions. One was a patient with recurrent 
carotid disease in whom the high-grade recurrent 
carotid stenosis was repaired, but who was believed to 
be too high a risk for further procedures. Proximal 
disease was suspected in the second patient on the 
basis of CFD findings; the patient underwent a 
carotid-to-carotid bypass procedure with concomi- 
tant carotid endarterectomy. 
DISCUSSION 
Cerebral arteriography as been an essential com- 
poncnt of thc preoperative valuation of patients 
being considered for carotid endarterectomy ever 
since the opcration was first performed more than 40 
years ago. In the early years of carotid surgery no 
alternatives toarteriography existed, but over the last 
decade CFD, and more recently MRA, have emerged 
as useful noninvasive tests to determine the presence 
of and quantitate the severity of carotid bifurcation 
disease. 
Although some investigators have cautiously sug- 
gested that angiography may be safely omitted in 
selected patients with unequivocal noninvasive stud- 
ies, 1~-~ others have insisted that cerebral arteriogra- 
phy remain a mandatory preoperative s tudy .  8'I9'26 To 
our lmowledge, only one published study has pro- 
spectively evaluated the additional contribution of 
arteriography to carefully performed noninvasive 
tests (duplex scanning) in a large series of patients. 
Dawson and associates xl evaluated 103 consecutive 
patients who were being considered for carotid en- 
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Table I. Indications in 30 patients who required cerebral arteriography 
No. whose management changed based on 
Indication No. of patients angiography findings 
50% to 79% stenosis by duplex scan with 10 6 
confounding variables such as unclear 
symptoms, question of ulceration, or
poor operative risk 
High-grade stenosis opposite carotid oc- 8 2 
clusion 
Suggestion fnon-atherosclerotic disease 4 0 
Confirm occlusion 3 2 
Suggestion fproximal disease 2 0 
Vertebrobasilar workup indicated 2 0 
Suboptimal noninvasive studies 1 0 
dartcrectomy who underwent both CFD and cerebral 
angiography and concluded that clinical assessment 
and CFD were sufficient for the preoperative evalua- 
tion of 93% of operative candidates. 
Advocates of routine preoperative c rebral arteri- 
ography cite the following reasons: (1) to detect 
incidental intracranial neurysms; (2) to detect intra- 
cranial carotid and middle cerebral artery stenosis; (3) 
a disappointing correlation was found between CFD 
and ar teriography inseveral studies; and (4) "no study 
proving benefit of endarterectomy compared with a 
nonsurgical randomized cohort has been conducted 
using only ultrasonographic evaluations."26 The ben- 
efits ofangiography are thought o outweigh the 0.4% 
to 1% risk of angiogram-induced stroke. 26 
Advocates of a more limited or selective use of 
cerebral arteriography question both the considerable 
expense associated with the procedure and the risk of 
significant complications, which include a mortality 
rate of 0.1% and a stroke risk of 1% to 4%. In the 
recently reported ACAS, 50% of the strokes in the 
group that was randomized to surgery occurred as a 
result of arteriography. 3 Many investigators also have 
questioned the clinical significance of the additional 
information provided by arteriography and the fre- 
quency with which it alters clinical decisionmaldng. 
Intracranial aneurysms were identified in 39 of the 
1500 cerebral arteriograms obtained as part of 
NASCET, yet only six (0.4%) were deemed clinically 
important. 26 Likewise, although CFD does not detect 
carotid siphon or intracranial arterial stenoses, such 
lesions do not appear to be a contraindieation to
carotid endarterectomy forhigh-grade stenosis. Mat- 
tos et al. 27 demonstrated severe siphon stenoses in less 
than 5% of patients. In addition, the presence of such 
lesions has not been found to increase ither early or 
late neurologic morbidity after carotid endarterec- 
tomy. 28 Concern over missed proximal brachioce- 
phalic lesions also appears to be unwarranted. Akers et 
al. 29 reviewed 1000 arch aortograms and identi- 
fied significant intrathoracic arterial stenoses in only 
1.8%, most of which were suspected on physical 
examination; one of the lesions that required surgery 
would have been missed if routine arteriography ad 
been omitted. 
Concerns about the accuracy of CFD have led 
some investigators to state that reliance on such 
studies is a "dubious presurgical strategy. ''26 It is 
important o note, however, that although many of 
the larger clinical trials relied heavily on arteriography, 
the CFD examinations frequently suffered from lack 
of standardization a d quality control. 3o It is undeni- 
able that in established vascular laboratories with 
well-trained personnel and ongoing quality control 
the accuracy of CFD approaches orexceeds 90% in the 
identification of >50% internal carotid stenoses. 8a4 
Moneta et al.2s recently published uplex criteria that 
correlate well with NASCET angiographic criteria for 
>70% stenosis. 
Numerous investigators have begun to cautiously 
advocate carotid endarterectomy on the basis of 
noninvasive studies alone. 11q4 Mattos et al. ~4 re- 
viewed 167 patients who underwent both CFD and 
carotid arteriography and reported that arteriography 
altered management in only 4% of patients. Although 
other investigators have corroborated these data, the 
evolution of a new technique, MRA, has led to the 
recommendation that CFD be followed by MRA. If 
the latter study confirms the CFD findings, it has been 
suggested that conventional rteriography may then 
be safely omitted. Polak et al. a~ and Turnipseed et 
al. 32'33 reportcd that with this combined approach, 
arteriography will be required in only 12% to 21% of 
patients. Although the performance of MRA may 
provide an added level of comfort by offering the 
clinician images that superficially resemble those from 
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conventional rteriograms, whether MRA offers any 
additional clinically useful information with sufficient 
frequency to justify its routine use is unclear. 
The controversies and uncertainties outlined 
above led us to prospectively study CFD, arteriogra- 
phy, and MRA in the evaluation of 103 candidates for 
carotid endarterectomy. Although all patients under- 
went both CFD and conventional rteriography, only 
48% were also studied with MRA. In the 70% of 
patients who had a clear-cut clinical picture and 
good-quality noninvasive studies, the arteriogram 
changed the clinical decision to operate in only one 
instance. In the other 30%, however, further informa- 
tion in the form of arteriography was desired. In this 
subgroup, the clinical decision was altered one third 
of the time. The most common situations in which 
management was altered were in six patients with 50% 
to 79% stenoses and atypical symptoms, in two 
patients with bilateral high-grade l sions on CFD, and 
in two patients in whom carotid occlusion was sug- 
gested by CFD but in whom string signs also were 
identified by conventional rteriography. The current 
MRA technology does not appear to produce images 
of sufficient quality to obviate arteriography, with the 
possible exception of ruling out pseudo-occlusion. 
Also, the aortic arch and supraaortic trunks cannot be 
reliably demonstrated. 
On the basis of this experience, we suggest that 
clinical evaluation and quality CFD are sufficient o 
evaluate approximately 70% of candidates for carotid 
endarterectomy. Such an approach is conservative, 
minimizes patient risk and diagnostic errors, and 
would result in significant cost savings. It is probably 
unrealistic to perform carotid endarterectomy in all 
symptomatic patients with >50% internal carotid 
artery stenosis by CFD as advocated by Dawson et 
al., 11 particularly in light of NASCET and ECST, 
which demonstrated the benefit of carotid endarter- 
ectomy only for stenoses >70%. 1'2 Until further data 
are available we believe angiography to be helpful in 
malting clinical decisions in many patients in whom 
CFD showed 50% to 70% lesions. 
Table II delineates the Medicare costs involved in 
the preoperative evaluation of carotid surgery patients 
with three possible scenarios: (1) the current standard 
approach (CFD and arteriogram in all patients); (2) 
CFD and MICA in all patients, with arteriogram in 
20%31; and (3) initial CFD with selective arteriogra- 
phy in 30% of patients, as recommended onthe basis 
of our data. The data were calculated with appropriate 
CPT codes and actual Medicare reimbursement fig- 
ures at University Medical Center (Tucson, Ariz.) 
rather than billed charges, which tend to overestimate 
Table II. Cost analysis: medicare 
reimbursement evaluation of 100 
consecutive patients 
Duplex scan and arteriography in 
all patients (100) $191,500 
Duplex scan and MRA (100) 
Selective arteriography (20) 
Duplex scan (100) 
Selective arteriography (30) 
63,531 
35,100 
$98,631 
16,000 
52~650 
$68,650 
true costs. The approach recommended here (initial 
CFD with selective arteriography in 30% of patients) 
would save almost $125,000 for the evaluation of 
every 100 candidates for carotid cndartcrectomy. 
The performance ofcarotid endarterectomy with- 
out angiography mandates the use of a well-equipped 
vascular laboratory with well-trained personnel and 
an established quality control record with correlation 
of CFD and angiographic findings based on extensive 
experience. Cut-off points for specific degrees of 
stcnosis hould bc established by each vascular labo- 
ratory. Because a small but significant portion of 
patients will still require arteriography, the laboratory 
should maintain an ongoing protocol to correlate 
angiographic and CFD findings to assure continued 
diagnostic accuracy. Absolute indications for conven- 
tional artcriography include: to confirm internal ca- 
rotid artery occlusion; the suggestion on noninvasive 
studies that disease is not limited to the carotid 
bifurcation (inability to visualize normal ICA abovc 
the stenosis or the suspicion of hemodynamically 
significant proximal diseasc); and to evaluate paticnts 
with nonatherosclerotic d sease. Relative indications 
for artcriography include patients with recurrent 
carotid stcnosis, patients with contralateral occlusion, 
and patients with severe bilateral disease. 
With the rapid development of high-quality, ap- 
proved vascular laboratories and an ever-increasing 
emphasis on cost control and the streamlining of 
patient care, wc suspect hat treatment algorithms 
based primarily on clinical findings and CFD will be 
applied more widely across the country. It is incum- 
bent on those who advocate such an approach to 
demand rigid standards of vascular laboratory quality 
control and accuracy. 
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